What does Biostar Pharmaceuticals, Inc. do?

Biostar Pharmaceuticals, Inc. (BSPM) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is BSPM's market cap?

Biostar Pharmaceuticals, Inc. (BSPM) has a market capitalization of approximately $264, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does BSPM pay a dividend?

No — Biostar Pharmaceuticals, Inc. (BSPM) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

BSPM

Biostar Pharmaceuticals, Inc.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$264.00·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.80%CAGR −71.15%

Select date range

FromTo

Dec 18, 2008Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

BSPM does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)−21.4%

EPS Growth (5Y)—

Next Earnings Date—

Last Report DateNov 20

Reported vs Estimate−$0.05

Earnings Surprise—

FinancialsFinancials Tab

Revenue$317.79K

Net Income$935.00K

Net Margin294.2%

Operating Cash Flow$8.59M

Capital Expenditures$0.00

Free Cash Flow$8.59M

Return on Equity2.6%

Return on Invested Capital−1.5%

Net Debt$2.06M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for BSPM and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how BSPM's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BSPM and 80,000+ other tickers.

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills…

CEO: Rong Hua Wang
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 200
Website: www.biostarpharmaceuticals.com

Peers

Peers Tab

CWWBF

Plant-Based Investment Corp.

Cap

$275.0

CRFTF

BC Craft Supply Co. Ltd.

Cap

$23.0

PEMTF

Thoughtful Brands Inc.

Cap

$368.0

Latest News

News Tab

No recent news available.

Frequently Asked Questions About BSPM

What does Biostar Pharmaceuticals, Inc. do?: Biostar Pharmaceuticals, Inc. (BSPM) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is BSPM's market cap?: Biostar Pharmaceuticals, Inc. (BSPM) has a market capitalization of approximately $264, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does BSPM pay a dividend?: No — Biostar Pharmaceuticals, Inc. (BSPM) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.